A Billionaire-Backed Startup Wants to Grow 'Organ Sacks' to Replace Animal Test
20 hours ago
- #biotechnology
- #organ-replacement
- #animal-testing-alternatives
- The Trump administration is phasing out animal experimentation, prompting biotech startup R3 Bio to propose 'organ sacks' as an ethical alternative.
- R3 Bio's organ sacks would contain typical organs but lack a brain, making them nonsentient and unable to feel pain.
- The company aims to create human versions for organ and tissue replacement, addressing shortages in donor organs.
- Monkey organ sacks are the initial focus, offering scalable and ethical testing models for drug development.
- China's ban on nonhuman primate exports has reduced US research monkey availability, increasing demand for alternatives.
- Organ sacks could surpass current organ-on-chip models by replicating full organ complexity, including blood vessels.
- Stem-cell technology and gene editing are being explored to create these organ sacks, potentially disabling brain development genes.
- Ethical concerns arise regarding the creation, storage, and maintenance of human organ sacks, though they are designed to lack sentience.
- R3 Bio is backed by investors like Immortal Dragons, Tim Draper, and LongGame Ventures, signaling strong industry interest.
- Public acceptance may be challenged by the 'yuck factor,' but the potential to alleviate organ shortages is significant.